Fuller & Thaler Asset Management’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-38,200
Closed -$454K – 600
2024
Q4
$454K Buy
38,200
+30
+0.1% +$511 ﹤0.01% 476
2024
Q3
$1.06M Sell
38,170
-131,660
-78% -$3.29M ﹤0.01% 383
2024
Q2
$4.05M Sell
169,830
-95,060
-36% -$2.23M 0.02% 324
2024
Q1
$4.66M Sell
264,890
-7,690
-3% -$113K 0.02% 311
2023
Q4
$4.3M Buy
272,580
+196,000
+256% +$2.02M 0.02% 296
2023
Q3
$659K Buy
+76,580
New +$544K ﹤0.01% 400

Other funds holding ASPN

Fuller & Thaler Asset Management's ASPN Position: Q1 2025 in Review

Fuller & Thaler Asset Management sold out of Aspen Aerogels (ASPN) in Q1 2025, closing a stake of 38,200 shares — an estimated $454K sold.

Fuller & Thaler Asset Management first reported a position in ASPN in Q3 2023 and held it in 6 quarters. The position peaked at $4.66M in Q1 2024. 221 funds tracked by Wall St. Rank hold ASPN as of Q1 2025.

  • Fuller & Thaler Asset Management reported no remaining Aspen Aerogels position as of Q1 2025 after selling out during the quarter.
  • Fuller & Thaler Asset Management sold 38,200 Aspen Aerogels shares in Q1 2025, an estimated $454K.
  • Fuller & Thaler Asset Management first reported a position in Aspen Aerogels in Q3 2023 and held it in 6 quarters.
  • Fuller & Thaler Asset Management's Aspen Aerogels position peaked at $4.66M in Q1 2024.
  • 221 funds tracked by Wall St. Rank held Aspen Aerogels as of Q1 2025.

Based on Fuller & Thaler Asset Management's 13F filing for Q1 2025, filed 13 May 2025.